Doug Hayden

3.5k total citations · 1 hit paper
25 papers, 2.7k citations indexed

About

Doug Hayden is a scholar working on Psychiatry and Mental health, Physiology and Epidemiology. According to data from OpenAlex, Doug Hayden has authored 25 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 8 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Doug Hayden's work include Schizophrenia research and treatment (10 papers), Diet and metabolism studies (5 papers) and Respiratory Support and Mechanisms (3 papers). Doug Hayden is often cited by papers focused on Schizophrenia research and treatment (10 papers), Diet and metabolism studies (5 papers) and Respiratory Support and Mechanisms (3 papers). Doug Hayden collaborates with scholars based in United States. Doug Hayden's co-authors include David C. Henderson, David Schoenfeld, Enrico Cagliero, Donald Goff, C. H. GRAY, Christina P. C. Borba, Paul M. Copeland, David M. Nathan, A. Eden Evins and Linda M. Delahanty and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Psychiatry and Neurology.

In The Last Decade

Doug Hayden

24 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study

2000 558 citations David C. Henderson, Enrico Cagliero et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Doug Hayden United States	22	1.1k	758	537	534	287	25	2.7k
Carolyn Watson United States	24	1.1k 0.9×	917 1.2×	281 0.5×	208 0.4×	791 2.8×	39	2.7k
Sebastiano Bruno Solerte Italy	32	575 0.5×	925 1.2×	478 0.9×	1.1k 2.0×	279 1.0×	72	2.9k
Paul M. Copeland United States	25	1.2k 1.0×	686 0.9×	254 0.5×	761 1.4×	191 0.7×	51	2.7k
Toby Pillinger United Kingdom	23	1.4k 1.2×	530 0.7×	426 0.8×	322 0.6×	279 1.0×	67	3.3k
Nicholas Moore United States	27	751 0.7×	276 0.4×	524 1.0×	151 0.3×	257 0.9×	73	2.8k
Paul Rolan Australia	32	892 0.8×	802 1.1×	704 1.3×	754 1.4×	664 2.3×	89	3.5k
Roberto Monastero Italy	35	1.6k 1.4×	1.0k 1.3×	397 0.7×	101 0.2×	182 0.6×	113	3.7k
Xi‐Peng Cao China	26	747 0.7×	1.1k 1.4×	535 1.0×	164 0.3×	98 0.3×	61	2.9k
J. M. Martínez‐Lage Spain	19	1.1k 1.0×	772 1.0×	278 0.5×	256 0.5×	134 0.5×	38	2.9k
Marc Combrinck United Kingdom	24	482 0.4×	525 0.7×	280 0.5×	422 0.8×	93 0.3×	38	2.1k

Countries citing papers authored by Doug Hayden

Since Specialization

Citations

This map shows the geographic impact of Doug Hayden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug Hayden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug Hayden more than expected).

Fields of papers citing papers by Doug Hayden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doug Hayden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug Hayden. The network helps show where Doug Hayden may publish in the future.

Co-authorship network of co-authors of Doug Hayden

This figure shows the co-authorship network connecting the top 25 collaborators of Doug Hayden. A scholar is included among the top collaborators of Doug Hayden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug Hayden. Doug Hayden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Xiaoduo, Christina P. C. Borba, Paul M. Copeland, et al.. (2012). Metabolic effects of adjunctive aripiprazole in clozapine‐treated patients with schizophrenia. Acta Psychiatrica Scandinavica. 127(3). 217–226. 46 indexed citations

Bley, Annette, et al.. (2011). Natural History of Infantile GM2 Gangliosidosis. PEDIATRICS. 128(5). e1233–e1241. 104 indexed citations

Cobb, J. Perren, Ernest E. Moore, Doug Hayden, et al.. (2009). Validation of the Riboleukogram to Detect Ventilator-Associated Pneumonia After Severe Injury. Annals of Surgery. 250(4). 531–539. 26 indexed citations

McClintock, Dana, Barry Starcher, Mark D. Eisner, et al.. (2006). Higher urine desmosine levels are associated with mortality in patients with acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 291(4). L566–L571. 40 indexed citations

Henderson, David C., Paul M. Copeland, Christina P. C. Borba, et al.. (2006). Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine. The Journal of Clinical Psychiatry. 67(5). 789–797. 44 indexed citations

Henderson, David C., Xiaoduo Fan, Paul M. Copeland, et al.. (2006). A double‐blind, placebo‐controlled trial of sibutramine for clozapine‐associated weight gain. Acta Psychiatrica Scandinavica. 115(2). 101–105. 52 indexed citations

Henderson, David C., Enrico Cagliero, Paul M. Copeland, et al.. (2005). Glucose Metabolism in Patients With Schizophrenia Treated With Atypical Antipsychotic Agents. Archives of General Psychiatry. 62(1). 19–19. 262 indexed citations

Henderson, David C., Richard F. Mollica, Svang Tor, et al.. (2005). Building Primary Care Practitioners’ Attitudes and Confidence in Mental Health Skills in a Post-Conflict Society. The Journal of Nervous and Mental Disease. 193(8). 551–559. 15 indexed citations

Henderson, David C., Dana D. Nguyen, Paul M. Copeland, et al.. (2005). Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality. The Journal of Clinical Psychiatry. 66(9). 1116–1121. 163 indexed citations

10.

Henderson, David C., Paul M. Copeland, Tara B. Daley, et al.. (2005). A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain. American Journal of Psychiatry. 162(5). 954–962. 98 indexed citations

11.

Henderson, David C., et al.. (2004). Clozapine and Hypertension: A Chart Review of 82 Patients. The Journal of Clinical Psychiatry. 65(5). 686–689. 66 indexed citations

12.

Feezor, Robert J., Henry V. Baker, Michael Mindrinos, et al.. (2004). Whole blood and leukocyte RNA isolation for gene expression analyses. Physiological Genomics. 19(3). 247–254. 164 indexed citations

13.

Delahanty, Linda M., Doug Hayden, Alice S. Ammerman, & David M. Nathan. (2002). Medical nutrition therapy for hypercholesterolemia positively affects patient satisfaction and quality of life outcomes. Annals of Behavioral Medicine. 24(4). 269–278. 30 indexed citations

14.

Tolkoff-Rubin, Nina, M.L. Farrell, Francis L. Delmonico, et al.. (2002). Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis c infection. Transplantation Proceedings. 34(5). 1771–1773. 22 indexed citations

15.

Delahanty, Linda M., Lillian Sonnenberg, Doug Hayden, & David M. Nathan. (2001). Clinical and Cost Outcomes of Medical Nutrition Therapy for Hypercholesterolemia. Journal of the American Dietetic Association. 101(9). 1012–1023. 69 indexed citations

16.

Henderson, David C., et al.. (2001). Risperidone Added to Clozapine. The Journal of Clinical Psychiatry. 62(8). 605–608. 35 indexed citations

17.

Thompson, B. Taylor, Doug Hayden, Michael A. Matthay, Roy G. Brower, & Polly E. Parsons. (2001). Clinicians’ Approaches to Mechanical Ventilation in Acute Lung Injury and ARDS. CHEST Journal. 120(5). 1622–1627. 61 indexed citations

18.

Henderson, David C., et al.. (2000). Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study. American Journal of Psychiatry. 157(6). 975–981. 558 indexed citations breakdown →

19.

Bogdanov, Mikhail, Robert H. Brown, Wayne R. Matson, et al.. (2000). Increased oxidative damage to DNA in ALS patients. Free Radical Biology and Medicine. 29(7). 652–658. 262 indexed citations

20.

Goff, Donald, Guochuan Tsai, James J. Levitt, et al.. (1999). A Placebo-Controlled Trial of D-Cycloserine Added to Conventional Neuroleptics in Patients With Schizophrenia. Archives of General Psychiatry. 56(1). 21–21. 342 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact